NIHTVBi019-A

HT852

General

Cell Line

hPSCreg name NIHTVBi019-A
Cite as:
NIHTVBi019-A (RRID:CVCL_B7SV)
Alternative name(s)
HT852
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
NIHTVBi019-A-1
(HT852-DC)
Donor diseases:
Leukodystrophy
PUFHi004-A
(TMEM163 c.227T>C p.(Leu76Pro) iPSC)
Donor's gene variants:
TMEM 163
Donor diseases:
Leukodystrophy
NIHTVBi022-A
(HT964)
Donor diseases:
Leukodystrophy
PFIZi029-A
(B222c4)
Donor's gene variants:
CHD2
Donor diseases:
myoclonic epilepsy
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
SHCDNi006-A
(SHCDN006)
Donor diseases:
epilepsy
PFIZi023-A
(B217c8)
Donor's gene variants:
GPR56, GPR56
Donor diseases:
Bilateral Frontoparietal Polymicrogyria
PFIZi025-A
(B220c16)
Donor's gene variants:
KCNC1
Donor diseases:
epilepsy
PNUSCRi004-A
(GBA PD iPSC8)
Donor diseases:
Parkinson Disease
SIAISi006-A
(JJY)
Donor diseases:
Alzheimer's Disease
MUNIi021-A
(sAD5)
Donor diseases:
Alzheimer's Disease
AIBNi016-A
(SPG2-S376C1)
Donor diseases:
hereditary spastic paraplegia 56
JUCGRMi003-A
(PH13)
Donor diseases:
Parkinson Disease
MUNIi011-A
(BAD1, sAD1)
Donor diseases:
Alzheimer's Disease
MUNIi012-A
(BAD2, sAD2)
Donor diseases:
Alzheimer's Disease
UMi041-A
(410730)
Donor diseases:
Alzheimer's Disease
JUCGRMi002-A
(DupA5)
Donor diseases:
Parkinson Disease
JUCGRMi002-B
(DupA13)
Donor diseases:
Parkinson Disease
BIOTi001-A
(BIOT-7183-PSEN1)
Donor's gene variants:
PSEN1
Donor diseases:
obsolete_Alzheimer's disease
JUCGRMi002-C
(DupA18)
Donor diseases:
Parkinson Disease
IPTi002-A
(15F0009)
Donor diseases:
obsolete_Alzheimer's disease
LNDWCHi001-A
(LNDWCH-iPS-PD-PLA2G6–001)
Donor diseases:
Parkinson Disease
UMi043-A
(AD 381852 clone #1)
Donor diseases:
Alzheimer's Disease
CBIGi002-A
(2890 (GBA W378G, heterozygous), 2890)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson Disease
CBIGi003-A
(3026, 3026 (GBA N370S, heterozygous))
Donor diseases:
Parkinson Disease
Last update 11th April 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
Owner National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA14026991
Cellosaurus CVCL_B7SV
Wikidata Q114312526

General Information

Publications
* Is the cell line readily obtainable for third parties?
No
Subclones

Donor Information

General Donor Information

Sex female
Ethnicity Caucasian/White

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Leukodystrophy

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes
Karyotyping method: G-Banding

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA14026314

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. Dr. Adeline Vanderver
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Please provide the contact information Dr. Adeline Vanderver
Alternatives to consent are available? No
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? National Heart, Lung, and Blood Institute (NHLBI)
Approval number Clinical Protocol number 10-H-0126.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A sample of peripheral blood mononuclear cells.
Synonyms
  • Peripheral Blood Mononuclear Cell Specimen
  • PBMC Specimen
  • PBMC Sample
  • Peripheral Blood Mononuclear Cell Sample
  • Peripheral Blood Mononuclear Cell (PBMC)
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Type of used vector free reprogramming factor(s)
None

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
SSEA-4
Yes
TRA 1-60
Yes
Score:
Marker Present Absent
mCpG
OCT4
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
AFP
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
HAND1
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
TUBB3
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
G-banding
Passage number: 19
Karyotyping method: G-Banding

Other Genotyping (Cell Line)